Thyroid cancer mortality statistics

Deaths

Deaths from thyroid cancer, 2016, UK

 

Proportion of all deaths

Percentage thyroid cancer is of total cancer deaths, 2016, UK

 

Age

Peak rate of thyroid cancer deaths, 2014-2016, UK

 

Trend over time

Change in thyroid cancer mortality rates since the early 1970s, UK

Thyroid cancer is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2016).[1-3]

In males in the UK, thyroid cancer is not among the 20 most common causes of cancer death (less than 1% of all male cancer deaths). In females in the UK it is not among the 20 most common causes of cancer death (less than 1% of all female cancer deaths).

36% of thyroid cancer deaths in the UK are in males, and 64% are in females.

Thyroid cancer mortality rates (European age-standardised (AS) rates Open a glossary item) are similar to the UK average in all the UK constituent countries.

Thyroid Cancer (C73), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2016

  England Scotland Wales Northern Ireland UK
Male Deaths 113 18 4 1 136
Crude Rate 0.4 0.7 0.3 0.1 0.4
AS Rate 0.5 0.8 0.3 0.1 0.5
AS Rate - 95% LCL 0.4 0.5 0.0 0.0 0.4
AS Rate - 95% UCL 0.6 1.2 0.6 0.3 0.6
Female Deaths 206 22 10 8 246
Crude Rate 0.7 0.8 0.6 0.8 0.7
AS Rate 0.7 0.7 0.5 0.8 0.7
AS Rate - 95% LCL 0.6 0.4 0.2 0.3 0.6
AS Rate - 95% UCL 0.8 1.1 0.9 1.4 0.8
Persons Deaths 319 40 14 9 382
Crude Rate 0.6 0.7 0.4 0.5 0.6
AS Rate 0.6 0.8 0.4 0.6 0.6
AS Rate - 95% LCL 0.6 0.5 0.2 0.2 0.6
AS Rate - 95% UCL 0.7 1.0 0.7 0.9 0.7

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016, ICD-10 C73.

Last reviewed:

Thyroid cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2014-2016, on average each year almost 6 in 10 (55%) deaths were in people aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for thyroid cancer in older people.

Age-specific mortality rates rise steadily from around age 40-44 and more steeply from around age 60-64. The highest rates are in the 85 to 89 age group for males and the 90+ age group for females.

Mortality rates are similar between males and females in most age groups. 

Thyroid Cancer (C73), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2014-2016

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2014-2016, ICD-10 C73.

Last reviewed:

Thyroid cancer European age-standardised (AS) Open a glossary item mortality rates for males and females combined decreased by 47% in the UK between 1971-1973 and 2014-2016.[1-3] The decrease was larger in females than in males.

For males, thyroid cancer AS mortality rates in the UK decreased by 27% between 1971-1973 and 2014-2016. For females, thyroid cancer AS mortality rates in the UK decreased by 52% between 1971-1973 and 2014-2016.

Over the last decade in the UK (between 2004-2006 and 2014-2016), thyroid cancer AS mortality rates for males and females combined remained stable.[1-3] In males AS mortality rates remained stable, and in females rates remained stable.

Thyroid Cancer (C73), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2016

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Thyroid cancer mortality rates have varied between age groups in males in the UK since the early 1970s.[1-3] Rates in 0-24s have remained stable, in 25-49s have decreased by 53%, in 50-59s have decreased by 65%, in 60-69s have decreased by 35%, in 70-79s have remained stable, and in 80+s have remained stable.

Thyroid Cancer (C73), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Males, UK, 1971-2016

Thyroid cancer mortality rates have decreased overall in most broad age groups in females in the UK since the early 1970s, but have remained stable in some.[1-3] Rates in 0-24s have remained stable, in 25-49s have decreased by 80%, in 50-59s have decreased by 69%, in 60-69s have decreased by 49%, in 70-79s have decreased by 59%, and in 80+s have decreased by 36%.

Thyroid Cancer (C73), European Age-Standardised Mortality Rates per 100,000 Population, By Age, Females, UK, 1971-2016

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2016, ICD-10 C73.

Last reviewed:

Thyroid cancer mortality rates are projected to rise by 7% in the UK between 2014 and 2035, to 1 death per 100,000 people by 2035.[1] This includes an increase for females and a drop for males.

For males, thyroid cancer European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 5% between 2014 and 2035, to 1 death per 100,000 by 2035.[1] For females, rates are projected to rise by 17% between 2014 and 2035, to 1 death per 100,000 by 2035.[1]

Thyroid cancer (C73), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

It is projected that 612 deaths from thyroid cancer (235 in males, 378 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C73

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is no evidence for an association between thyroid cancer mortality and deprivation for either males or females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are similar for both males and females living in the most deprived areas compared with the least deprived.[1]

Thyroid Cancer (C73), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in thyroid cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C73

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

There were around 6,300 deaths from thyroid cancer in Europe in 2012 (0.4% of total cancer deaths). In Europe (2012), the highest World age-standardised Open a glossary item mortality rates for thyroid cancer are in Iceland for men and Russia for women; the lowest rates are in Malta and Montenegro for men and Luxembourg for women. UK thyroid cancer mortality rates are estimated to be the 6th lowest in males in Europe, and 9th lowest in females.[1] These data are broadly in line with Europe-specific data available elsewhere.[2]

There were around 37,800 deaths from thyroid cancer worldwide in 2012 (0.5% of total cancer deaths). Thyroid cancer mortality rates are highest in Melanesia and lowest in Northern Europe, but this partly reflects varying data quality worldwide.[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed December 2013. 
  2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer (2013) 49, 1374-1403.

About this data

Data is for: Europe and worldwide, 2012, ICD-10 C73

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.3 out of 5 based on 8 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page